2017 Roundtable Summit on Health & Wellness and CEO Roundtable on Cancer-China IV





Dear Member CEOs,

You are cordially invited to participate in the 2017 Summit on Health & Wellness and the 4th Annual CEO Roundtable on Cancer-China co-hosted by Shanghai Health Academy of Chinese Academy of Sciences (CAS) and CEO Roundtable on Cancer. This meeting is supported by the Bio-Med Big Data Center, CAS-MPG Partner Institute for Computational Biology (PICB), Chinese Academy of Sciences (CAS).

Date & Time: April 19, 2017; 1:00pm - 6:00pm

Venue: Soon to be announced

As our premier event in 2017, this CEO Roundtable & Summit will feature in-depth and comprehensive discussions on new discoveries, new tools and new trends in health and wellness, and it will showcase new learnings and achievements from various sectors in health promotion fostering a culture in support of Healthy China 2030 goals.

You are invited to participate in the development of the major topics of this meeting including the role of science in health and wellness management in this new era for China, and how innovation and new technologies may support a healthy society. Our Summit will be enriched with the strong participation from government, health professionals and industry leaders, and with you as an attendee who will be asked to help us advance innovation, strengthen public policy and improve health care whilst promoting healthy lifestyles.

Please send your request for attendance and/or event agenda to Louise.Lu@CEORoundtableOnCancer.org before Wednesday, April 12, 2017 should you be interested in joining.

On behalf of the CEO Roundtable and Summit organizers, Shanghai Health Academy of CAS and CEO Roundtable on Cancer, we thank you for your leadership and for your ongoing commitment to our common noble mission.

With only choicest regards, we remain




Prof. Guoping ZHAO

Chief Scientist

Shanghai Health Academy, SIBS, CAS



Dr. Martin J. Murphy

Chief Executive Officer

CEO Roundtable on Cancer

VIP Participants (partial)

  • Prof. CHEN Zhu, President, Red Cross Society of China

  • Prof. WANG Yu, Director General, China CDC

  • Robert A. Bradway, CEO, Amgen

  • Dr. Riccardio Braglia, CEO, Helsinn

  • Sean Khozin, MD, MPH, Senior Medical Officer, US FDA

  • Prof. ZHAO Guoping, Chief Scientist, Shanghai Health Academy, SIBS, CAS

  • Dr. Martin J. Murphy, CEO, CEO Roundtable on Cancer, Founding Executive Editor, The Oncologist, Stem Cells and Stem Cells Translational Medicine

And C-suite leadership from CEO Roundtable on Cancer-China Member companies including:

  • Amgen

  • AstraZeneca

  • Baxter

  • Boehringer Ingelheim

  • Bristol-Myers Squibb

  • Celgene

  • Cigna & CMB

  • Helsinn Healthcare SA

  • Johnson & Johnson

  • Lenovo

  • Merck Biopharma China

  • MSD

  • Sanofi

  • SAS Institute

  • Thermo Fisher Scientific




我们诚挚邀请您出席由中国科学院上海健康院与CEO Roundtable on Cancer联合主办,上海健康院生物医学大数据中心协办的“卫生与健康科学2017圆桌论坛”暨第四届防癌抗癌总裁圆桌会中国年会。







谨代表会议主办方,中国科学院上海健康院及CEO Roundtable on Cancer向您表示衷心感谢,感谢您的杰出领导和为健康公益事业做出的贡献!真诚期待着您莅临指导!



赵国屏 院士






CEO Roundtable on Cancer


  • 中国红十字会会长陈竺博士
  • 中国疾病预防控制中心主任王宇博士
  • 安进公司全球总裁、CEO Roundtable on Cancer主席Robert Bradway先生
  • 赫尔森保健公司首席执行官Dr. Riccardio Braglia
  • 美国FDA高级医学官Sean Khozin博士
  • 上海健康院生物医学大数据中心首席科学家赵国屏院士
  • CEO Roundtable on Cancer首席执行官,《肿瘤学家》、《干细胞》和《干细胞转化医学》创始执行主编马丁·墨菲博士

以及来自CEO Roundtable on Cancer中国会员企业的管理层代表,包括:

  • 安进
  • 阿斯利康
  • 百特
  • 勃林格殷格翰
  • 百时美施贵宝
  • 新基
  • 招商信诺
  • 赫尔森保健
  • 强生
  • 联想
  • 默克雪兰诺
  • 默沙东
  • 赛诺菲
  • 赛仕软件
  • 赛默飞世尔